Pfizer: sell signal at week 5

Pfizer: the decline hasn't confirmed, but risks remain

Pfizer is in week 5 of a sell signal that has not confirmed: short-term indicators show growing buy-side pressure and a double bottom in the 25 area. The picture remains fragile, with trading not recommended.

12 June 2026 · 43 min read min read

Pfizer · Sell signal, week 5

In Summary

Pfizer is in week 5 of a sell signal that has not confirmed. The short-term structure has stiffened around a double bottom in the 25 area, and indicators show persistent buy-side pressure — a picture that weakens the bearish case. Trading not recommended per our model; those already short find here the week-by-week read.

Ongoing decline ·5th week from start ·US stocks ·T2 ★ See Gold version →

IQS Phase

in tension

Signal Strength

indecisive week

Sizing

MINIMUM

Ranking

#32 / 114

US stocks

Trade P&L %

-2.06%

from signal to today

Chart · Weekly — EMA50 · MACD · VWAP

Weekly chart · EMA50 · MACD · VWAP · Source: TradingView

How to read this pageA visual guide to the post, card by card→

The full analysis, operating plan and detailed levels on this asset are reserved for clients ★ PLATINUM

restricted Platinum content